Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 10Carcinoma, Ovarian Epithelial 8Sarcoma 4Neurotoxicity Syndromes 4Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Uterine Cervical Neoplasms 3Testicular Neoplasms 3Breast Neoplasms 3Teratoma 2Small Cell Lung Carcinoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Germ Cell Cancer 2Neuroectodermal Tumors, Primitive, Peripheral 2Neuroblastoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Kidney Neoplasms 2Hodgkin Disease 2Endometrial Neoplasms 2Drug-Related Side Effects and Adverse Reactions 2Central Nervous System Neoplasms 2Burkitt Lymphoma 2Wilms Tumor 1

Interventions

Methotrexate 6Dactinomycin 6Drug Therapy 4camrelizumab 3Vacuum Curettage 3Flow Cytometry 3toripalimab 2pembrolizumab 2apatinib 2Psychiatric Rehabilitation 2Methylprednisolone 2Leucovorin 2Immunologic Techniques 2Filgrastim 2Etoposide 2Cyclophosphamide 2Carboplatin 2Alemtuzumab 2zimberelimab 1sargramostim 1dostarlimab 1dexamethasone acetate 1dexamethasone 21-phosphate 1carotuximab 1aldesleukin 1Vincristine 1Thrombopoietin 1Tacrolimus 1Surveys and Questionnaires 1Surgical Procedures, Operative 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gestational Trophoblastic Disease × Amifostine × Gynecologic × Clear all
NCT00058071 2013-07-09

Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer

GOG Foundation

Phase 3 Completed
100 enrolled
Gynecologic

Hydatidiform Mole, Peripheral Nervous System Diseases, Neurotoxicity Syndromes, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡